Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
32
33
Next >
Thoughts For Thursday: Risk-Off, Risk-On
February 09, 2023
Tickers
ABBV
GILD
MASI
PFE
Tags
ETFs
Market News
Pharma/Biotech
From
TalkMarkets
Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer
February 09, 2023
Tickers
BCTX
Tags
Pharma/Biotech
Market News
From
TalkMarkets
NeurAxis: Should You Buy This IPO?
February 08, 2023
Tickers
ABBV
AMGN
ARNA
BMY
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
TalkMarkets
The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week
February 07, 2023
Tickers
AAWH
ACB
ACRDF
CYBN
Tags
Pharma/Biotech
Stocks / Equities
Consumer Goods
From
TalkMarkets
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution
February 06, 2023
Tickers
ABBV
AMGN
ARNA
BMY
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
How The 5 Cannabis Categories Performanced Last Week
February 05, 2023
Tags
Market News
Healthcare
Consumer Goods
From
TalkMarkets
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
Tickers
ARKG
CRSP
CYRX
EVH
Tags
ETFs
Market News
Pharma/Biotech
From
TalkMarkets
6 Largest Psychedelic Stocks Down 3% This Week
February 04, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
February 04, 2023
Tickers
GH
GPCR
GRCL
IVBXF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
January 30, 2023
Tickers
ABBV
ABT
IBB
IHI
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
TalkMarkets
A Comparison Of 7 Cannabis Portfolio Performances YTD And Last Week
January 30, 2023
Tickers
AAWH
CGC
CRON
MAPS
Tags
ETFs
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
The "Rags-To-Riches" Portfolio Update: Week Ending January 27
January 29, 2023
Tickers
ATAI
BYND
CGC
CMPS
Tags
Healthcare
Consumer Goods
Market News
From
TalkMarkets
The "Multi-Bagger" Portfolio Update: Week Ending January 27
January 29, 2023
Tickers
ACB
ACRDF
CYBN
OGI
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Summary Of Cannabis Category Performances, Week Ending Friday Jan. 27
January 28, 2023
Tickers
AAWH
ACB
CGC
FORA
Tags
Consumer Goods
Healthcare
Market News
From
TalkMarkets
Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug
January 28, 2023
Tickers
ASCLF
HCM
LEGN
SBHMY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD
January 28, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Stock Analysis:: Takeda Pharmaceutical
January 23, 2023
Tickers
TAK
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
AZN Stock Under Pressure
January 23, 2023
Tickers
AZN
Tags
Market News
Healthcare
Stocks / Equities
From
TalkMarkets
The "Multi-Bagger" Portfolio Update: January 20th, 2023
January 22, 2023
Tickers
ACB
ACRDF
OGI
SEEL
Tags
Market News
Consumer Goods
Healthcare
From
TalkMarkets
"Rags-To-Riches" Portfolio Update: Week Ending January 20, 2023
January 22, 2023
Tickers
ATAI
BYND
CGC
CRON
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
TalkMarkets
Roundup: 5 Cannabis Category Performances
January 22, 2023
Tickers
ACB
CGC
GRWG
MNMD
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
January 21, 2023
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
January 21, 2023
Tickers
GNNSF
IRON
ROSS
SDGR
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
AstraZeneca’s Next “Wonder Drug”
January 19, 2023
Tickers
AZN
DSNKY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
January 18, 2023
Tickers
BCTX
BCTXW
INCY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer
January 18, 2023
Tickers
BCTX
BCTXW
TM
Tags
Market News
Pharma/Biotech
From
TalkMarkets
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
January 17, 2023
Tickers
ABBV
ABT
ARKG
BMY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
JHM Biopharma Raised Over CNY 100 Mn in Series A+
January 15, 2023
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
6 Largest Psychedelic Stocks Jumped 11% Last Week
January 15, 2023
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
3 Top Canadian Psychedelic Stocks For January 2023
January 14, 2023
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.